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Background
Visceral leishmaniasis, a disease caused by Leishmania
infantum chagasi, represents a major public health pro-
blem in many areas of the world. Despite the consider-
able effort, there is no effective and safe vaccine for
human use [1]. Some authors have reported that as much
as 50% of overall costs in the biotechnology industries
are related to downstream processing. Thus, the develop-
ment of new and economically advantageous purification
methods is a challenge [2]. Expanded bed adsorption
(EBA) is an innovative chromatography technology that
allows the adsorption of target proteins directly from
unclarified feedstock. EBA technology combines solid-
liquid separation with an adsorption step in a single-unit
operation, aiming at increased overall yield, reduced
operational time, and less capital investment and con-
sumables [3,4]. Thus, the aim of this work was to purify
the 503 antigen of Leishmania i. chagasi directly from
crude feedstock using EBA chromatography.
Methods
The strain of E. coli expressing 503 antigen of Leishmania i.
chagasi was kindly provided by Dr. Mary Wilson (Univer-
sity of Iowa, USA) [1]. The clone was cultured in 2xTY
medium supplemented with antibiotics [5]. The cultivations
were carried out using a bench bioreactor with a work
volume of 1.5 L, at frequency of agitation of 400 rpm and
constant output aeration of 1 vvm. The expression of the
recombinant protein was induced by the addition of lactose
10 g/L. Optimization of adsorption and elution conditions
of 503 antigen was performed in batch mode according to
two central composite designs. Then, EBA using Streamline
Chelating was employed to purify 503 antigen from unclari-
fied bacterial homogenate with a glass column (30.0 cm ×
2.6 cm I.D) and an adjustable piston, in order to minimize
headspace over the fluidized bed. Analysis of the fractions
was performed by Lowry method and electrophoresis on
15% polyacrylamide gels under denaturing conditions. The
gels were photographed to estimate protein production,
using the software ImageJ.
Results and conclusions
The batch adsorption experiment with Streamline Che-
lating showed that the optimal binding condition of 503
antigen was pH 8.0 in the presence of 1.625M NaCl. The
optimal elution condition for the elution of protein of
interest from the adsorbent was in the presence of
600mM imidazole. The adsorption isothermal data of
503 antigen onto Streamline Chelating showed that the
data obeyed the Langmuir adsorption isotherm. The EBA
assays showed that bed height increased linearly with the
linear flow velocity. The fraction recovered after the elu-
tion contained 25% of the initial amount of 503 antigen.
In conclusion, EBA has been applied successfully to pur-
ify the 503 antigen from an E. coli homogenate. The EBA
mode combined clarification, capture, and purification of
the interesting protein in a single step process, thereby
giving rise to a good product recovery.
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